COVID-19 Vaccine Candidate Prevents Severe Clinical Disease in Animals
Cummings School researchers contribute to study in hamsters that’s among first to report vaccine protection against severe COVID-19-related pneumonia and death
Dept. of Infectious Disease and Global Health
EEE: Lower impact than expected in 2020
Professor Sam Telford spoke with Boston 25 about why human EEE cases in Massachusetts are lower than expected so far in 2020
Tufts University to lead $100M program to reduce risk of zoonotic viral spillover, spread
The STOP Spillover program will involve large consortium of wildlife and human disease experts from Cummings School, the university, and organizations across the world.
The COVID Mink Crisis, Explained
Professor Jonathan Runstadler spoke with NBCNews.com about the COVID-19 outbreaks at Dutch mink farms
Coronavirus FAQs
Professor Jonathan Runstadler contributed his expertise to NPR’s Goats and Soda for a coronavirus FAQ on a range of topics
Keeping an Eye on the Human-Animal Interface
Infectious disease researchers Kaitlin Sawatzki, Nichola Hill, and Wendy Puryear spoke with Nature’s LabAnimal on viral surveillance at the human-animal interface
FDA Authorizes a Third COVID-19 Vaccine
Cummings School veterinary pathologist aided research behind new single-dose vaccine from Johnson & Johnson
Racing to save humans through animal research
Professor Jonathan Runstadler comments on his lab's work studying SARS-CoV-2 and the potential for transmission between humans and animals in a @avmajournals story about the contributions from veterinary researchers around the virus
Tufts in Sweet 16 for STAT Madness
Sameer Sonkusale and his group’s research on a pill that samples gut microbes is still in the running for best innovations in biomedicine, and needs your vote